Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Tamada

Showing results (61-70 of 61) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 61 results.
The New England Journal of Medicine|February 20, 2019
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell CarcinomaBrian I Rini, Elizabeth R Plimack, Viktor Stus, et al.
Pageof 7

Showing results (61-70 of 61) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 61 results.
The New England Journal of Medicine|February 20, 2019
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell CarcinomaBrian I Rini, Elizabeth R Plimack, Viktor Stus, et al.
Pageof 7